The experimental drug Tykerb has been shown to reduce the spread of breast cancer when combined with Xeloda, in a study led by Dr. Charles Geyer, Jr.
The combination of the 2 drugs almost doubled the delay when compared to trials done on Xeloda alone.
Tykerb belongs to a class of drugs that are more specifically-targeted
The benefit is they kill less healthy tissue than older varieties.
Tykerb is also similar in action to Herceptin, but slightly more specific in its targeting.
As a Footnote:
The Breast Cancer Prevention Program, by Samuel Epstein
and Your Life In Your Hands, by Jane Plant will both be added to “Book Reviews” here in the future.
Hopefully further research and books like these may one day supplant the need for drugs like Tykerb, etc.